Hyperfine PRIME trial shows portable MRI cuts ED time-to-imaging to 1.28 hours

Hyperfine, Inc. Class A

Hyperfine, Inc. Class A

HYPR

0.00
  • Hyperfine announced results from its PRIME emergency-department trial, already presented at the Society for Academic Emergency Medicine 2026 annual meeting.
  • The randomized study found bedside use of its portable Swoop brain MRI cut delays to imaging versus the standard workflow.
  • Scans in the portable-MRI arm identified clinically urgent findings that were later confirmed on conventional MRI, supporting its use for faster triage decisions.
  • The readout strengthens the company’s push to position portable MRI as a workflow tool for hospitals facing limited access to conventional MRI capacity.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyperfine Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260522721021) on May 22, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.